DermTech (DMTK) Misses Q4 EPS by 15c

DermTech (NASDAQ: DMTK) reported Q4 EPS of ($0.88), $0.15 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.4 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• InspireMD (NSPR) Tops Q2 EPS by 1c